Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium : YAG laser posterior capsulotomy

Unal M., Yucel I., Akar Y.

JOURNAL OF CATARACT AND REFRACTIVE SURGERY, vol.32, no.9, pp.1499-1502, 2006 (SCI-Expanded) identifier identifier identifier


PURPOSE: To compare the efficacy of brinzolamide 1% with that of apraclonidine 0.5% in preventing intraocular pressure (IOP) rise after neodymium:YAG (Nd:YAG) laser posterior capsulotomy.